Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).
Di Marco, V., Calvaruso, V., Ferraro, D., Bavetta, M., Cabibbo, G., Conte, E., et al. (2016). Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension. GASTROENTEROLOGY, 151(1), 130-139.e2-139.e2 [10.1053/j.gastro.2016.03.036].
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
DI MARCO, Vito;CALVARUSO, Vincenza;FERRARO, Donatella;BAVETTA, Maria Grazia;CABIBBO, Giuseppe;CONTE, Elisabetta;CAMMA', Calogero;GRIMAUDO, Stefania;PIPITONE, Rosaria Maria;SIMONE, Fabio;CRAXI, Antonio
2016-01-01
Abstract
Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gastroenterology 2016.pdf
Solo gestori archvio
Dimensione
1.05 MB
Formato
Adobe PDF
|
1.05 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
